| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.124 | 54.713 | 68.903 | 81.907 | 136.997 | 123.504 | 153.546 | 185.818 | 210.208 | 265.637 |
| Total Income - EUR | 41.125 | 54.716 | 68.905 | 81.910 | 137.002 | 127.849 | 156.585 | 185.833 | 221.461 | 265.644 |
| Total Expenses - EUR | 14.596 | 28.641 | 41.864 | 50.949 | 50.789 | 65.198 | 68.248 | 87.220 | 99.115 | 127.929 |
| Gross Profit/Loss - EUR | 26.528 | 26.075 | 27.041 | 30.961 | 86.212 | 62.651 | 88.337 | 98.613 | 122.347 | 137.715 |
| Net Profit/Loss - EUR | 25.529 | 25.528 | 26.098 | 30.142 | 84.839 | 61.396 | 86.942 | 97.034 | 120.641 | 130.923 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Dinu Uromedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.854 | 22.152 | 15.362 | 9.927 | 5.252 | 58.556 | 44.427 | 36.299 | 81.614 | 53.151 |
| Current Assets | 15.673 | 41.128 | 51.737 | 68.727 | 86.026 | 71.081 | 87.132 | 151.209 | 129.210 | 212.312 |
| Inventories | 0 | 0 | 0 | 50.761 | 50.223 | 48.126 | 47.059 | 47.205 | 21.032 | 41.925 |
| Receivables | 8.971 | 35.423 | 42.565 | 8.828 | 5.223 | 2.749 | 7.169 | 23.422 | 26.559 | 25.321 |
| Cash | 6.702 | 5.705 | 9.172 | 9.138 | 30.580 | 20.207 | 32.904 | 80.582 | 81.619 | 145.067 |
| Shareholders Funds | 25.574 | 24.636 | 50.318 | 45.713 | 70.343 | 78.276 | 90.389 | 158.034 | 194.299 | 132.210 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 953 | 38.643 | 16.781 | 33.622 | 21.603 | 52.017 | 42.374 | 29.474 | 16.574 | 133.287 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dinu Uromedica Srl